Main logo
?
tutorial arrow
×
Create your own tool library
Bookmark tools and put favorites into folders to find them easily.

DAVID | A biological module-centric algorithm to functionally analyze large gene lists

Online

A web-based online bioinformatics resource that aims to provide tools for the functional interpretation of large lists of genes/proteins. DAVID has been used by researchers from more than 5000 institutes worldwide, with a daily submission rate of approximately 1,200 gene lists from approximately 400 unique researchers, and has been cited by more than 17,000 scientific publications.

User report

tutorial arrow
×
Vote up tools and offer feedback
Give value to tools and make your expertise visible
Give your feedback on this tool
Sign up for free to join and share with the community

0 user reviews

star_border star_border star_border star_border star_border
star star star star star

0 user reviews

star_border star_border star_border star_border star_border
star star star star star

No review has been posted.

DAVID forum

tutorial arrow
×
Communicate with other users
Participate in the forum to get support for using tools. Ask questions about technical specifications.
Take part in the discussion
Sign up for free to ask question and share your advices

No open topic.

DAVID classification

DAVID specifications

Unique identifier:
OMICS_02220
Interface:
Web user interface, Application programming interface
Computer skills:
Basic
Stability:
Stable
Name:
Database for Annotation, Visualization and Integrated Discovery
Restrictions to use:
None
Version:
6.7
Maintained:
Yes

Credits

tutorial arrow
×
Promote your skills
Define all the tasks you managed and assign your profile the appropriate badges. Become an active member.
Promote your work
Sign up for free to badge your contributorship

Publications

Institution(s)

Laboratory of Immunopathogenesis and Bioinformatics, Clinical Services Program, SAIC-Frederick, Inc; National Cancer Institute at Frederick, Frederick, MD, USA

By using OMICtools you acknowledge that you have read and accepted the terms of the end user license agreement.